Hepatocellular Carcinoma Recurrence and Anesthesia

NCT02643173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 259

Last updated 2019-11-22

No results posted yet for this study

Summary

The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.

Conditions

Interventions

OTHER

Volatile anesthetics

OTHER

Intravenous anesthetics

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02643173 on ClinicalTrials.gov